Patents by Inventor Martine Peter

Martine Peter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

FULL LENGTH LARGE T TUMOR ANTIGEN OF MERKEL CELL POLYOMAVIRUS AS A THERAPEUTIC TARGET IN MERKEL CELL CARCINOMA

Publication number: 20110182901

Abstract: The invention relates to a full length Large T tumor antigen of Merkel Cell Polyomavirus (MCV) as a therapeutic target in Merkel Cell Carcinoma (MCC).

Type: Application

Filed: January 11, 2011

Publication date: July 28, 2011

Applicant: INSTITUT CURIE

Inventors: Martine PETER, Xavier SASTRE-GARAU
Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors, and nucleic acids of fusion resulting from said translocations

Patent number: 5968734

Abstract: Translocations of chromosome 22 are associated with various cancers. Hybrid DNA sequences, having a portion of the Ews gene of chromosome 22 and a portion of either the Hum-Fli-1 gene of chromosome 11, the Erg gene of chromosome 21, or the Atf-1 gene of chromosome 12, are disclosed. Proteins encoded by these hybrid DNAs are disclosed. Diagnosis of specific cancers based on detection of the translocations is disclosed.

Type: Grant

Filed: January 18, 1995

Date of Patent: October 19, 1999

Assignee: (CNRS Centre National de la Recherche Scientifique

Inventors: Alain Aurias, Olivier Delattre, Chantal Desmaze, Thomas Melot, Martine Peter, Beatrice Ploougastel, Gilles Thomas, Jessica Zucman

FULL LENGTH LARGE T TUMOR ANTIGEN OF MERKEL CELL POLYOMAVIRUS AS A THERAPEUTIC TARGET IN MERKEL CELL CARCINOMA

Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors, and nucleic acids of fusion resulting from said translocations